Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company that develops new treatments for rare genetic diseases. According to its filings, it lobbies on issues related to rare disease and patient access, including medical and clinical research concerns. The filings show one disclosure and no reported spending for the most recent period.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ASHLEY GUNN
The latest disclosures for this client.
MILLER STRATEGIES, LLC
RRThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.
MILLER STRATEGIES, LLC
JEFFREY MILLER
MILLER STRATEGIES, LLC
NATALIE MCINTYRE
MILLER STRATEGIES, LLC